Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
Hansen OP, Pedersen-Bjergaard J, Ellegaard J, Brincker H, Boesen AM, Christensen BE, Drivsholm A, Hippe E, Jans H, Jensen KB, et al. Hansen OP, et al. Among authors: hippe e. Leukemia. 1991 Jun;5(6):510-6. Leukemia. 1991. PMID: 2056774 Clinical Trial.
Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AML.
de Nully Brown P, Hoffmann T, Hansen OP, Boesen AM, Grønbaek K, Hippe E, Jensen MK, Thorling K, Storm HH, Pedersen-Bjergaard J. de Nully Brown P, et al. Among authors: hippe e. Leukemia. 1997 Jan;11(1):37-41. doi: 10.1038/sj.leu.2400514. Leukemia. 1997. PMID: 9001416 Clinical Trial.
Tumor cell concentration and tumor burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin's disease. The Danish National Hodgkin Study Group.
Specht L, Lauritzen AF, Nordentoft AM, Andersen PK, Christensen BE, Hippe E, Hou-Jensen K, Nissen NI. Specht L, et al. Among authors: hippe e. Cancer. 1990 Jun 1;65(11):2594-601. doi: 10.1002/1097-0142(19900601)65:11<2594::aid-cncr2820651133>3.0.co;2-#. Cancer. 1990. PMID: 2337876
Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase III study. Nordic Myeloma Study Group (NMSG).
Keldsen N, Bjerrum OW, Dahl IM, Drivsholm A, Ellegaard J, Gadeberg O, Gimsing P, Grønvold T, Hansen MM, Hippe E, et al. Keldsen N, et al. Among authors: hippe e. Eur J Haematol. 1993 Aug;51(2):80-5. doi: 10.1111/j.1600-0609.1993.tb01597.x. Eur J Haematol. 1993. PMID: 8370422 Clinical Trial.
Vitamin B12 metabolism in myelomatosis.
Hansen OP, Drivsholm A, Hippe E. Hansen OP, et al. Among authors: hippe e. Scand J Haematol. 1977 May;18(5):395-402. doi: 10.1111/j.1600-0609.1977.tb02093.x. Scand J Haematol. 1977. PMID: 877515
133 results